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Introduction
Insomnia is a common problem in the general population (e.g 1) and is known to be associated with psychiatric and somatic comorbidities (2, 3, 4, 5) . The diagnosis is characterised by difficulties initiating and/or maintaining sleep as well as residual daytime symptoms three times a week or more often during a period of 3 months or more (6) . The perception of good or bad sleep is also related to age and gender (7, 8, 9) . Insomnia may influence different aspects of life, and in a review by Kyle et al. (10) it was concluded that insomnia has a negative influence on different aspects of health-related quality of life (HRQoL), adequate treatment of insomnia can, however, lead to significant improvements.
Insomnia can be measured in various ways, objective as well as subjective (e.g. 11). When it comes to objective measurements, polysomnography (PSG) is considered to be the golden standard of sleep assessment (12) . PSG can be performed in the laboratory or at home.
Despite the fact that PSG can be used to determine the different sleep stages and the total sleep time, it is not primarily used to diagnose insomnia, but rather other sleep disorders such as narcolepsy, sleep disordered breathing disorders and parasomnia (12) . Actigraphy is another objective method to measure physical activity, and it is also, indirectly, used to study sleep-wake patterns by assessing movement (13) . The actigraph is a portable device, measuring movements by being attached to the non-dominant wrist. One of the advantages of actigraphy is that, in comparison to PSG, it is possible to record many days and nights without a significant intrusion in a person's everyday life. It also allows the patient to sleep in the natural sleep environment. According to a review by Ancoli-Israel et al. (13) the majority of the literature shows that the reliability and validity of actigraphy is moderate to high in differentiating sleep from wake in a healthy population. Vallières et al. (14) performed a study where actigraphy was compared to PSG and sleep diary. The results confirmed actigraphy as a reliable method for assessing insomnia disorder. In a population with fragmented sleep, the reliability of actigraphy was questioned by Paquet et al. (15) , who performed a study using actigraphy and PSG during one nocturnal sleep episode and two daytime recovery sleep episodes. The results, in accordance with previous research by Sivertsen et al. (16) , demonstrated that actigraphy was less reliable than PSG for detecting wakefulness (15) . Rowe et al. (17) however found that a minimum measurement period of seven days was required to obtain reliable information regarding sleep parameters. To establish insomnia diagnosis, subjective methods such as a clinical interview according to the diagnostic and statistical manual of mental disorders, fifth edition (DSM-5) criteria (6) , combined with self-report questionnaires, is standard procedure. A sleep diary or sleep log can also be used to monitor the sleep-wake pattern. Insomnia symptoms are subjective (18) and the experience of the   symptoms, measured with subjective measurements, does not necessarily correlate with the   objective measurements since persons with insomnia tend to underestimate their total sleep time as well as overestimating time spent awake in bed (19) . While objective measurements can show an improved actual sleep time after an intervention, subjective measurements may not necessarily reflect the improvement (19, 20, 21, 22) .
There are various ways to treat insomnia. Over the last two decades interest has increased in developing non-pharmacological insomnia treatments, an effort that enables reduction of hypnotic drug dosages as well as side effects (23) . The most effective non-pharmacological treatment is cognitive behavioral therapy for insomnia (CBT-i) (24) . The components of CBT-i include cognitive techniques addressing common insomnia-related features such as rumination and dysfunctional beliefs and attitudes towards sleep, and behavioral techniques addressing practical aspects such as sleep restriction (e.g 25). Another non-pharmacological treatment that has been tested to treat insomnia is acupuncture (26) . Acupuncture is a complementary treatment method, which to some extent is used in the health care system, for example within maternity care and pain management (27) . Auricular acupuncture (AA) is a branch of traditional acupuncture and has also been used to treat insomnia (22, 28, 29, 30) .
Given that objective measurements do not always correlate with subjective measurements and that there are very few studies of AA for insomnia where objective measurements of the sleep patterns are used (22, 31, 32) , we found it important to report the effects of CBT-i and AA with an objective sleep measurement. In a recent study we compared the treatment effects of AA and CBT-i regarding the subjective symptoms of insomnia severity (33), using the Insomnia Severity Index (ISI) (34) as the primary outcome. The results showed that CBT-i significantly improved subjective insomnia symptoms compared to AA.
In the present report our aim was to use an objective measurement method, actigraphy, to examine how sleep patterns were affected in a short-and long-term perspective after AA-and CBT-i, as well as to compare sleep parameters related to these patterns between the two treatment forms.
Materials and Methods
This was a prospective randomized controlled study (RCT) using actigraphy to examine sleep patterns and evaluate treatment effects of AA and CBT-i in a short-and long-term perspective.
Participants
The participants and the inclusion-and exclusion criteria and the procedure are described in detail in Bergdahl et al. (33) . To briefly summarize, participants in the study sample, 51 women and 9 men (N=60), with a mean age of 60.5 (SD 9.4) years, had experienced insomnia symptoms for more than six months. All had used non-bensodiazepine hypnotics for a mean of 7.3 years (SD 5.6), but even with the pharmacological treatment the insomnia symptoms persisted and the participants wanted to end their medication. All participants were instructed to end their hypnotic drug treatment three to five days before the treatment start.
Procedure
Participants were recruited by advertisement in the local newspaper and from an outpatient sleep clinic. All subjects were informed that participation was voluntary and that they could withdraw from the study at any time without any negative consequences. In total 204 persons were assessed for eligibility. The 67 participants who fulfilled the inclusion criteria met with an experienced medical sleep specialist (senior author AM) who assessed all subjects before inclusion. After signing the informed consent form, the participants were given an actigraph to wear on their non-dominant wrist. Instructions on how to use it were given verbally and in writing; participants were instructed to wear the actigraph during seven days and nights in order to register 24-hour activity patterns, where the focus was the sleep periods. To indicate when they went to bed at night and when they rose in the morning they were instructed to press the actigraphy event marker. During the inclusion session the participants also completed the SF-12. Follow-up actigraphy recordings and SF-12 was performed directly post-treatment and six months after the end of the treatment.
Randomization to group treatment with AA (n=32) or CBT-i (n=35) was carried out after the inclusion session. The randomization procedure is described in detail in Bergdahl et al. (33) .
For participant flow during the study, see Figure 1 . 
The treatments
Extended treatment descriptions are given in Bergdahl et al. (33) , and only summarized briefly below. Both treatments were performed in hospital facilities for outpatients.
AA
The AA group (n=27) was scheduled for treatment sessions twice a week during four weeks.
The standardised National Acupuncture Detoxification Association (NADA) protocol, according to the Nogier's European ear map, was used. The acupuncture points used in the NADA protocol are Shen Men, Sympathetic, Kidney, Liver and Lung. In a previous study it was shown that this point selection might have contributed to an improved sleep (35) . It has not however, except for the study by Bergdahl et al. (33) , previously been tested as a standalone treatment for insomnia disorder. Two NADA-trained members of the psychiatric medical staff, who had long experience of using the method, performed the treatment. During every treatment session, which lasted for 45 minutes, the participants received five acupuncture needles in each outer ear, inserted at a depth of three millimetres. Once inserted there was no stimulation of the needles, and after the insertion the acupuncturist left the room.
The participants were seated in chairs during the entire time, and when the session was over the acupuncturist removed the needles.
Equipment
Sterile stainless Zhongyan Taihe acupuncture needles (0.18 x 13 mm) were used. The needles were disposed of after every treatment. Disinfectant solution on the participants' outer ears and the acupuncturists' hands was used before needle insertion.
CBT-i
Twenty-nine participants initiated the CBT-i treatment and received a manual-based group treatment (36) once a week during six weeks. The sessions lasted for 90 minutes and included guidance in sleep restriction, information about sleep physiology, how to cope with sleeping problems, maintaining factors and stimulus control and relaxing techniques. Three licensed clinical psychologists delivered the treatment; all had prior CBT training and were experienced in delivering CBT-i treatment.
Measurements

Actigraphy
The MotionWatch 8® actigraph, (CamNtech Ltd, Cambridge, UK) was used to assess the participants' 24-hours activity pattern and to distinguish sleep from time awake.
The MotionWatch 8 is a light-weighted, wrist-worn tri-axial accelerometer designed to monitor long-term or short-term activity. The sensitivity for movement lies within 0.01 g to 8 g and 3 to 11 Hz, and the recorded movements are measured in epochs (i.e time intervals). In 
Ethics
The project was approved by the Regional Ethical Vetting Board in Uppsala (ref. number 2012/353) and the trial was registered in the ClinicalTrials.gov database (ID: NCT01765959).
Results
The actigraph results, presented in minutes and in percentages as well as effect sizes and pvalues, are presented in Table 1 and Table 2 . The SF-12 results are presented in Table 3 .
Actigraph recording -within-groups results
Significant interactions occurred within the groups. Compared to baseline, the CBT-i group went to bed 29.7 (7. Table 2 . Interactions between the groups and Cohen's delta (Cohen's d); between baseline to post-treatment and between baseline to 6-month follow-up, presented in estimates and standard error (SE). * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001.
SF-12
Measurements were made between and within the groups regarding the MCS and PCS at baseline, one week after the treatment and at 6-month follow-up. No significant interactions between the groups were found. Only the CBT-i group showed significant within-group changes; in MCS and PCS there were significant changes post-treatment compared to baseline (3.4 (1.7) (p<0.05); 3.3 (1.6) (p<0.05)), and in PCS there was also a significant interaction at the 6-month follow-up compared to the baseline (3.7 (1.8) (p<0.05)). The within-groups results are presented in Table 3 . 
Discussion
In the previous study (33) , where subjective symptoms of insomnia were measured after AA and CBT-i, it was concluded that AA was not considered as a sufficient stand-alone treatment for insomnia. The aim of this report was to use actigraphy to objectively study and compare how sleep patterns were affected over time after AA-and CBT-i.
The results showed that the actual sleep time and time in bed increased in the AA group and decreased in the CBT-i group after the treatments when compared to baseline. The CBT-i group also managed to significantly reduce their actual wake time in bed. There were significant improvements of the sleep latency within both groups after the treatment, a result that was maintained in the CBT-i group at the 6-month follow-up. The sleep efficiency in the CBT-i group improved as well after the treatment, but was not maintained six months later.
According to the between-group actigraph recordings, there were significant changes in wake- Regarding HRQoL there were positive changes in MCS and PCS within the CBT-i group after the treatment, a result that is in accordance with a previous study of Espie et al. (42) .
There were no significant interactions between the treatment groups.
Limitations
These results are limited to women in the age group represented in this study; thus we do not know if the result is generalizable to other age groups or to men. The number of men is low and it would have been interesting to study if their sleep patterns changed in the same ways as for the women. Due to the limited number of men however, it was not possible to do in this study.
Conclusion
The results from these objective actigraph recordings showed that the AA group slept more and the CBT-i group slept less after the treatments and that sleep patterns in both groups reverted to pre-treatment levels after six months. Taken together with our previous findings the results show that despite increased sleep time the insomnia symptoms did not decrease within the AA group. The CBT-i group, on the contrary, reduced their sleep time and also reduced their insomnia symptoms. Thus, AA, as given in this study, does not improve insomnia symptoms to the same extent as CBT-i and cannot be considered as a sufficient stand-alone treatment. Sleep time does not necessarily affect the perception of insomnia symptoms, and prolonged sleep time does not automatically yield better sleep.
